Press Releases
Neptune Reports on Active Pharmaceutical Ingredient (API) Preclinical Research; Significant HDL Increase Confirmed Print
Thursday, November 05 2009
Neptune announced today the second preclinical research up-date on Acasti Pharma Inc. (“Acasti”) drug development program.
 
Neptune Reports on Active Pharmaceutical Ingredient Preclinical Research Print
Thursday, October 29 2009

--Neptune announced today the first preclinical research up-date on Acasti Pharma Inc. (“Acasti”) drug development program. --

 
Neptune Technologies reports first quarter results and updates Print
Wednesday, July 15 2009
--Plant and capacity expansion, Board appointment and Acasti Pharma--
 
Acasti Pharma Inc. reports fiscal 2009 results and scientific update Print
Tuesday, June 30 2009
Acasti Pharma Inc. reports fiscal 2009 results and scientific update
 
Acasti Pharma Inc. reports quarterly results Print
Thursday, January 29 2009
Acasti Pharma Inc. reports quarterly results
 


Safe and effective
pharmaceutical and
medical applications...